High-flow Nasal Oxygenation During Deep Sedation in Pediatric Dental Patients
Launched by PEKING UNIVERSITY · Feb 27, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the use of high-flow nasal oxygen during deep sedation in young children who need dental treatment. The researchers want to see how well this method works and whether it is safe for kids aged 3 to 7 years old who will be undergoing procedures that are expected to take more than an hour.
To be eligible for this study, children must need deep sedation for their dental work and be within the specified age range. However, if a child has certain health conditions or allergies that could make them unsuitable for this type of sedation or the use of high-flow nasal oxygen, they may not be able to participate. If a child is enrolled in the study, their parents can expect careful monitoring to ensure their safety and comfort during the dental procedures. Overall, this trial aims to improve the way we help children feel calm and breathe well during dental treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. children in need of deep sedation for dental treatment aged 3-7 years.
- • 2. anticipated operation time over 60 mins.
- Exclusion Criteria:
- • 1. Conditions which the attending considers to be unfit for elective surgery or tubeless anesthesia.
- • 2. Any contraindications of high flow nasal oxygenation.
- • 3. Any contraindications or allergic history of propofol.
About Peking University
Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials